Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biopsy-proven Diabetic Nephropathy in People With Type 2 Diabetes. Prevalence and Predictive Factors

NCT04916132 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT04916132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04916132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biopsy-proven Diabetic Nephropathy in People With Type 2 Diabetes. Prevalence and Predictive Factors
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 10, 2021
Completion date
December 31, 2043
Enrollment
300 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, chronic kidney diseases, diabetes type2, diabetic kidney disease, diabetic nephropathies, kidney biopsy, molecular sequence variation